Cohnreznick LLP

New York, NY Professional servicesNAICS 541211

Self-funded health planPlan year 2024Renews January
3,816ParticipantsFirst year on file
$9.0MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#9 of 70Professional services in NYBy participants

Overview

Cohnreznick LLP sponsors a self-funded health plan that covered 3,816 participants in plan year 2024. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
3,816
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Cohnreznick LLP Employee Benefits Program for Active Employees, plan 515 (3,816 participants); Cohnreznick LLP Benefits Program for Retired Partners Under Age 65, plan 520 (2,847 participants)
Broker compensation
$804K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Delta Dental of PennsylvaniaDental5,445$9.0M$269K
Sun Life and Health Insurance CompanyLife, Short-term disability, Long-term disability3,808$1.8M$249K
UnitedHealthcare Insurance CompanyVision5,085$947K$44K
Aetna Life Insurance CompanyAccident, Critical Illness, Hospital3,069$587K$163K
Express Scripts, Inc.Prescription drug115$343K$11K
United American Insurance CompanyMedical115$194K$17K
United of Omaha Life Insurance CompanyLife342$153K$24K
Legalplans, USALegal567$133K$27K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$9.0M/ year

Estimated prescription spend: 3,816 participants × $2,371 national average per member. Usually higher once dependents are counted.

$235K–$580K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$69K–$172K
Lower-cost therapeutic alternatives$100K–$210K
Generic pricing vs. actual cost$43K–$130K
PBM contract terms$23K–$68K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2024
Plan sponsor
Cohnreznick LLP
Sponsor EIN
22-1478099
Plan numbers
515, 520
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 22-1478099 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Cohnreznick LLC 401(k) Profit Sharing Plan
Type
401(k) plan
Participants
5,485

About this data

Source: Cohnreznick LLP's Form 5500 filing for plan year 2024 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Cohnreznick LLP.

Request a correction · Methodology